You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 246 No. 2, July 10, 1981 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Airway Response to Sublingual Nitroglycerin in Acute Asthma

Thomas Kennedy, MD, MPH; Warren R. Summer, MD; Jimmie Sylvester, MD; David Robertson, MD

JAMA. 1981;246(2):145-147.


Abstract

To test the efficacy of sublingual nitroglycerin as a bronchodilator, we studied ten patients with acute asthma. After a baseline spirogram, each patient was given 1.2 mg of sublingual nitroglycerin, and subsequent spirograms were obtained at five-minute intervals for 15 minutes. Each patient was then given three subsequent doses of epinephrine (0.5 mg) subcutaneously at 15-minute intervals. Spirograms were obtained 15 minutes after each epinephrine dose. Forced expiratory volume at 1 s (FEV1) and forced vital capacity (FVC) did not change significantly following sublingual nitroglycerin, but both FEV1 and FVC improved significantly after epinephrine administration. Three patients experienced transient but severe hypotension after receiving sublingual nitroglycerin. The results suggest that sublingual nitroglycerin is not adequate initial therapy for asthmatic attacks and that the administration of sublingual nitroglycerin in acute asthma may be dangerous.

(JAMA 1981;246:145-147)



Author Affiliations

From the Departments of Environmental Health Sciences (Dr Kennedy) and Medicine (Drs Summer and Sylvester), The Johns Hopkins Medical Institutions, Baltimore, and the Department of Medicine (Dr Robertson), Vanderbilt University School of Medicine, Nashville, Tenn.


Footnotes

Reprint requests to Johns Hopkins Hospital, 600 N Wolfe St, Brady 404, Baltimore, MD 21205 (Dr Kennedy).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nitric oxide sensitivity in pulmonary artery and airway smooth muscle: a possible role for cGMP responsiveness
Taniguchi et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 2006;290:L1018-L1027.
ABSTRACT | FULL TEXT  

NO responsiveness in pulmonary artery and airway smooth muscle: the role of cGMP regulation
Kwak et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 2006;290:L200-L208.
ABSTRACT | FULL TEXT  

Nitric Oxide in Health and Disease of the Respiratory System
Ricciardolo et al.
Physiol. Rev. 2004;84:731-765.
ABSTRACT | FULL TEXT  

Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function
Hamad et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 2003;285:L973-L983.
ABSTRACT | FULL TEXT  

The Utility of Nitric Oxide in the Postoperative Period
Body and Shernan
SEMIN CARDIOTHORAC VASC ANESTH 1998;2:4-30.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.